UNITED THERAPEUTICS Corp financial data

Symbol
UTHR on Nasdaq
Location
Silver Spring, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 29 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 598% % 40%
Quick Ratio 26% % 73%
Debt-to-equity 12% % -35%
Return On Equity 19% % -2%
Return On Assets 17% % 3.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43,056,599 shares -3.6%
Common Stock, Shares, Outstanding 42,902,818 shares -3.8%
Entity Public Float $12,155,535,434 USD 33%
Common Stock, Value, Issued $800,000 USD 14%
Weighted Average Number of Shares Outstanding, Basic 43,800,000 shares -1.8%
Weighted Average Number of Shares Outstanding, Diluted 47,300,000 shares -2.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,128,400,000 USD 14%
Research and Development Expense $544,300,000 USD 9.2%
Costs and Expenses $1,634,900,000 USD 11%
Operating Income (Loss) $1,493,500,000 USD 17%
Nonoperating Income (Expense) $172,900,000 USD 9.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,666,400,000 USD 16%
Income Tax Expense (Benefit) $394,700,000 USD 21%
Net Income (Loss) Attributable to Parent $1,271,700,000 USD 14%
Earnings Per Share, Basic 28 USD/shares 17%
Earnings Per Share, Diluted 26 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,340,100,000 USD -14%
Marketable Securities, Current $1,427,500,000 USD -19%
Accounts Receivable, after Allowance for Credit Loss, Current $297,700,000 USD -13%
Inventory, Net $176,500,000 USD 20%
Other Assets, Current $252,200,000 USD 36%
Assets, Current $3,494,000,000 USD -13%
Deferred Income Tax Assets, Net $354,900,000 USD -9.2%
Property, Plant and Equipment, Net $1,555,600,000 USD 34%
Goodwill $32,300,000 USD -4.2%
Other Assets, Noncurrent $262,600,000 USD 43%
Assets $7,351,100,000 USD 3.2%
Accounts Payable, Current $6,000,000 USD 7.1%
Employee-related Liabilities, Current $94,200,000 USD 29%
Accrued Liabilities, Current $338,500,000 USD 16%
Liabilities, Current $546,300,000 USD -37%
Other Liabilities, Noncurrent $214,600,000 USD 44%
Liabilities $760,900,000 USD -26%
Accumulated Other Comprehensive Income (Loss), Net of Tax $100,000 USD -99%
Retained Earnings (Accumulated Deficit) $8,192,600,000 USD 18%
Stockholders' Equity Attributable to Parent $6,590,200,000 USD 8%
Liabilities and Equity $7,351,100,000 USD 3.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $461,200,000 USD 22%
Net Cash Provided by (Used in) Financing Activities $93,800,000 USD 91%
Net Cash Provided by (Used in) Investing Activities $164,700,000 USD -122%
Common Stock, Shares Authorized 245,000,000 shares 0%
Common Stock, Shares, Issued 75,708,024 shares 1.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $202,700,000 USD 363%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,340,100,000 USD -14%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,400,000 USD -57%
Deferred Tax Assets, Valuation Allowance $30,100,000 USD -2.3%
Deferred Tax Assets, Gross $562,900,000 USD 19%
Depreciation $19,600,000 USD 32%
Payments to Acquire Property, Plant, and Equipment $74,900,000 USD 96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,264,400,000 USD 8.8%
Lessee, Operating Lease, Liability, to be Paid $38,600,000 USD 18%
Property, Plant and Equipment, Gross $2,104,200,000 USD 29%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,000,000 USD 40%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,100,000 USD 30%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,100,000 USD 45%
Deferred Tax Assets, Operating Loss Carryforwards $19,800,000 USD -7.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $19,600,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,800,000 USD 38%
Depreciation, Depletion and Amortization $19,800,000 USD 32%
Deferred Tax Assets, Net of Valuation Allowance $532,800,000 USD 20%
Share-based Payment Arrangement, Expense $135,700,000 USD 1.6%
Interest Expense $58,800,000 USD 42%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%